0
Autolus Therapeutics plc Banner Image

Autolus Therapeutics plc has reached its limit for free report views

Work for Autolus Therapeutics plc? Upgrade Your Profile and unlock all your annual reports.

Autolus Therapeutics plc

  • Ticker AUTL
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Autolus Therapeutics plc Logo Image
  • 201-500 Employees
  • Based in London, England
Autolus is a clinical-stage biopharmaceutical company developing next-generation, programmed T cell therapies for the treatment of cancer. Using a broad suite of proprietary and modular T cell programming technologies, the company is engineering precisely targeted, controlled and highly active T cell therapies that are designed to better recognize cancer cells, break down their defenseMore mechanisms and eliminate these cells. Autolus has a pipeline of product candidates in development for the treatment of hematological malignancies and solid tumors.
Autolus Therapeutics plc

Most Recent Annual Report

Autolus Therapeutics plc MOST RECENT 2019 Annual Report

Report Locked. Autolus Therapeutics plc has reached its limit for free report views.

Older/Archived Annual Reports